Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system (2022)
- Authors:
- USP affiliated authors: ARRUDA, GUSTAVO VIANI - FMRP ; ROCHA, MARINA TOLEDO LOURENÇÃO - FEARP ; OLIVEIRA, JORGE HENRIQUE CALDEIRA DE - FEARP
- Unidades: FMRP; FEARP
- DOI: 10.1016/j.lana.2022.100329
- Subjects: RADIOTERAPIA; NEOPLASIAS PULMONARES; SISTEMA DE SAÚDE; SISTEMA ÚNICO DE SAÚDE
- Keywords: Stereotactic body radiotherapy; Conventional fractionation; Surgically ineligible stage I non-small cell lung cancer; Radiotherapy; Cost-effectiveness
- Language: Inglês
- Imprenta:
- Source:
- Título: The Lancet Regional Health - Americas
- ISSN: 2667-193X
- Volume/Número/Paginação/Ano: v. 14, art. 100329, p. 1-9, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ARRUDA, Gustavo Viani et al. Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system. The Lancet Regional Health - Americas, v. 14, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2022.100329. Acesso em: 28 fev. 2026. -
APA
Arruda, G. V., Lourenção, M. T. de A., Oliveira, J. H. C. de, Galendi, J. S. C., & Jacinto, A. A. (2022). Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system. The Lancet Regional Health - Americas, 14, 1-9. doi:10.1016/j.lana.2022.100329 -
NLM
Arruda GV, Lourenção MT de A, Oliveira JHC de, Galendi JSC, Jacinto AA. Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system [Internet]. The Lancet Regional Health - Americas. 2022 ; 14 1-9.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1016/j.lana.2022.100329 -
Vancouver
Arruda GV, Lourenção MT de A, Oliveira JHC de, Galendi JSC, Jacinto AA. Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system [Internet]. The Lancet Regional Health - Americas. 2022 ; 14 1-9.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1016/j.lana.2022.100329 - Cost-effectiveness of BRCA 1/2 genetic test and preventive strategies: using real-world data from an upper-middle income country
- Creation and implementation of collective brands: an analysis of the Brazilian wine sector challenges
- Destination advertisement semiotic signs: Analysing tourists visual attention and perceived ad effectiveness
- Desenvolvimento de modelo de identidade para marca setorial: um estudo sobre a marca Brasil Fashion System
- Comunicação da marca-país de destino do Brasil em anúncios promocionais de turismo: um estudo da atenção visual e da atitude de turistas estrangeiros e residentes
- Generation Z response toward sponsorship disclosure on Instagram: where do they look? what do they perceive? how do they act?
- Economic and image impacts of summer Olympic games in tourist destinations: a literature review
- Eficácia e segurança da betaterapia adjuvante pós-ressecção de pterígio: ensaio clínico randomizado com metanálise
- Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: a meta-analysis
- In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials.”. [Carta]
Informações sobre o DOI: 10.1016/j.lana.2022.100329 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003277804.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
